Kuros Biosciences AG CSBTF:OTCPK

RT Quote | Exchange | USD
Last | 02/19/21 EST
2.54UNCH (UNCH)
52 week range
1.57 - 3.40

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.54
  • 52 Week High3.40
  • 52 Week High Date06/15/20
  • 52 Week Low1.57
  • 52 Week Low Date05/07/20
  • Market Cap61.13M
  • Shares Out24.37M
  • 10 Day Average Volume338
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.63
  • P/E (TTM)-4.02
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Kuros Biosciences AG News

There is no recent news for this security.

Latest CSBTF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Kuros Biosciences AG is a Switzerland-based biotechnology company engaged in the discovery, development and commercialization of biopharmaceutical products known as Immunodrugs. Immunodrugs are therapeutic vaccines intended for treating and preventing common chronic diseases, such as hypertension, nicotine addiction, allergic diseases, asthma, malignant melanoma and Alzheimer's disease. They are designed to instruct the patient's immune system to produce desired therapeutic...
Clemens van Blitterswijk Ph.D.
Chairman
Leanna Caron
Vice Chairman
Joost de Bruijn
Chief Executive Officer
Michael Grau
Chief Financial Officer
Jason Schense
Chief Technology Officer
Address
Wagistrasse 25
Schlieren
8952
Switzerland